Blocknomi
TLDR Shares of Novo Nordisk rallied more than 6% following FDA’s proposal to remove semaglutide, tirzepatide, and liraglutide from the 503B compounding bulks list The regulatory agency stated no medical…
Related articles
-
Hong Kong targets 10,000 BTC in purchases for Asia’s first regulated Bitcoin capital pool
CryptoSlate Published 26.04.2026 15:00
-
Tracking PR Results by Outlet: A Framework for Post-Campaign Analysis
Crypto Daily Published 24.04.2026 18:04
-
Validator Identity as the Next Test of Institutional Blockchain Adoption
BeInCrypto Published 24.04.2026 09:24
-
Hack at Vercel sends crypto developers scrambling to lock down API keys
CoinDesk Published 20.04.2026 01:47
-
Coinbase-incubated Base launches Azul testnet upgrade with multiproofs to advance decentralization
The Block Published 22.04.2026 10:56
-
XRP (XRP) Price Analysis: Whales Drive 94% of Exchange Outflows Amid Institutional Accumulation
Blocknomi Published 25.04.2026 07:08
-
A Collection Of Ripple Developments That Suggests XRP Is A Solid Buy
Bitcoinist Published 21.04.2026 15:30
-
MegaETH Activates First KPI, Starts MEGA Token Countdown
Blocknomi Published 23.04.2026 19:35